BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3354733)

  • 1. Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles gynecologists: possible implications for public health.
    Ross RK; Paganini-Hill A; Roy S; Chao A; Henderson BE
    Am J Public Health; 1988 May; 78(5):516-9. PubMed ID: 3354733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient.
    Weinstein L
    Obstet Gynecol; 1987 Jun; 69(6):929-32. PubMed ID: 3574823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
    McGonigle KF; Karlan BY; Barbuto DA; Leuchter RS; Lagasse LD; Judd HL
    Gynecol Oncol; 1994 Oct; 55(1):126-32. PubMed ID: 7959253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S; Currie H; Mikkola TS; Dragon E
    Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids.
    Sherwin BB; Gelfand MM
    Obstet Gynecol; 1989 May; 73(5 Pt 1):759-66. PubMed ID: 2704504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal estrogens--current prescribing patterns of San Diego gynecologists.
    Barrett-Connor E
    West J Med; 1986 May; 144(5):620-1. PubMed ID: 3716427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy.
    Tannen RL; Weiner MG; Xie D; Barnhart K
    Hum Reprod; 2007 Jun; 22(6):1769-77. PubMed ID: 17347166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials.
    Perez MV; Wang PJ; Larson JC; Virnig BA; Cochrane B; Curb JD; Klein L; Manson JE; Martin LW; Robinson J; Wassertheil-Smoller S; Stefanick ML
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1108-16. PubMed ID: 23169946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and progestin supplementation.
    Nurse Pract; 1995 Mar; 20(3):63-6. PubMed ID: 7761042
    [No Abstract]   [Full Text] [Related]  

  • 13. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progestin therapy to prevent osteoporosis: attitudes and practices of general internists and gynecologists.
    Greendale GA; Carlson KJ; Schiff I
    J Gen Intern Med; 1990; 5(6):464-9. PubMed ID: 2266426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
    Power ML; Zinberg S; Schulkin J
    Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Ross RK; Paganini-Hill A; Wan PC; Pike MC
    J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on continuous estrogen-progestin replacement therapy.
    Rosenfeld JA
    Am Fam Physician; 1994 Nov; 50(7):1519-23, 1527-8. PubMed ID: 7976988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens.
    Padwick ML; Pryse-Davies J; Whitehead MI
    N Engl J Med; 1986 Oct; 315(15):930-4. PubMed ID: 3762595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone therapy with estrogens and gestagens in peri- and post-menopause].
    Emons G
    Internist (Berl); 2008 May; 49(5):553-8. PubMed ID: 18345528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.